Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2008-003337-24-IT
EUCTR2008-003337-24-IT
Active, not recruiting
Not Applicable

Diagnostic imaging in prostate cancer (as in tumours with accelerated menbrane turn-over)by F-18 Fluoro-metil-choline PET/CT - F-18 Fluoro-metil-choline on PET/CT

CENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA0 sitesOctober 25, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionspatients with prostate cancer istologically provenMedDRA version: 14.1Level: SOCClassification code 10038359Term: Renal and urinary disordersSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 14.1Level: SOCClassification code 10022891Term: InvestigationsSystem Organ Class: 10022891 - InvestigationsTherapeutic area: Diseases [C] - Cancer [C04]

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
patients with prostate cancer istologically proven
Sponsor
CENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA
Status
Active, not recruiting
Last Updated
12 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 25, 2012
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Male

Investigators

Sponsor
CENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA

Eligibility Criteria

Inclusion Criteria

  • •locally advanced (previously treated as well) and metastatic prostate cancer istologically proven
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range: 0
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 60
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 10

Exclusion Criteria

  • •oAge \<30 yrs o \>90 yrs
  • •o Gleason \>8\.
  • •oPSA \<0\.2ng/ml

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Imaging of Metastatic Prostate Cancer Tumors Using 68Ga-NTA-14Metastatic Prostate CancerCancer - Prostate
ACTRN12621001704886St. Vincent's Hospital Sydney Limited10
Active, not recruiting
Phase 1
Imaging of the prostate tumors using PET/CT and PET/MRI with the ligand of the prostatic specific membrane antigene 68Ga-PSMA-11prostatic carcinoma higly suspected or its staging or restagingTherapeutic area: Diseases [C] - Male diseases of the urinary and reproductive systems [C12]
EUCTR2017-004128-32-CZFakultní nemocnice Plzen200
Recruiting
Not Applicable
Evaluation of new PET tracer, [F-18]Florastamin for diagnosing prostate cancer: Phase I clinical trial
KCT0004817FutureChem10
Completed
Not Applicable
Novel Imaging in Staging of Primary Prostate CancerHigh Risk Prostate Cancer
NCT03537391Turku University Hospital80
Recruiting
Not Applicable
Evaluation of new PET tracer, [F-18]Florastamin for diagnosing prostate cancerNeoplasms
KCT0003924Korea Cancer Center Hospital6